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I. INTRODUCTION
Sometime late in 1982, Carlotta Locklear, a 27-year old resident of
New Haven, Connecticut, gave birth to a son. It must surely be a sign
of the times in medical jurisprudence that an event as humanly ordi-
nary as childbirth is coming with increasing frequency to be attended
with puzzling legal consequences. The doctors at Yale-New Haven
Hospital first realized the difficulty of the legal problems that Ms.
Locklear's case would occasion when they diagnosed her baby's seri-
ous illness as AIDS. The baby had almost certainly contracted AIDS
in utero, and Mrs. Locklear was therefore presumably a carrier. She
was also a prostitute and a heroin addict, placing her in two of the risk
categories for AIDS.
Ordinarily, Ms. Locklear's doctors would have an ethical and legal
obligation of confidentiality in respect of the information about her
condition, but no conscientious doctor would ignore the enormous
public health hazard involved. As an illicit intravenous drug user with
a $200-a-day habit, Ms. Locklear would expose other drug users to
AIDS; as a young prostitute with no other means to support an expen-
sive drug addiction and an ailing baby, she would expose her custom-
ers to it.1 On the other hand, she was then free of symptoms and could
only be presumed to be an AIDS carrier, rather than positively diag-
nosed as a victim of the disease. Should the public health authorities
be alerted? Connecticut's relatively limited disease-reporting laws did
not seem to apply to her case. Hospital confinement was not a legally
available alternative either, for although she would later die of one of
the opportunistic infections that typically kill AIDS sufferers, she was
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1. This is probably what Ms. Locklear's doctors would have believed in 1982. How-
ever, the popular press has recently reported that AIDS may be far less transmis-
sible through vaginal sexual intercourse between a female AIDS victim and a
male. Its sexual transmission from men to women is apparently far more com-
mon. AIDS: Myths and Reality, NEWswEEK, Sept. 23, 1985, at 20, 21.
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not then a hospital patient, and no quarantine law applied. In any
event, much of the doctors' power to protect Ms. Locklear's confiden-
tial medical information was destroyed by a series of magazine and
newspaper articles, and finally a segment of CBS's weekly "60 Min-
utes" about Ms. Locklear.2 The publicity in turn prompted the Con-
necticut Legislature to enact a quarantine law that would apply to
future AIDS patients.3
In the course of the public controversy about her condition, Ms.
Locklear offered to give her unfortunate son up for adoption. Here too
the law and existing legal institutions were patently inadequate to re-
solve the problems presented. Even though for relatively long periods
her young son was free from symptoms and not under any active med-
ical treatment, no state institution - no school, no day-care facility, no
custodial home - would admit him, no family could be found in which
to place him, and the law provided no alternatives for his care.4 As a
result, he lived the few years of his short life almost entirely within
the walls of, and under the care of, Yale-New Haven Hospital. By late
1983 there had already been thirty-six known American cases of AIDS
among children, most of them children of intravenous drug users,5
and the legal problems of these children, and of the health care profes-
sionals who treat them, can be expected to loom increasingly large as
the number of diagnosed AIDS cases doubles every ten months.6
The bramblebush of hard issues in Carlotta Locklear's case is unu-
sual primarily for the publicity that it attracted, as the progress of
AIDS has everywhere thrown up a myriad of difficult legal issues.
These range from issues of research confidentiality (a topic of discus-
sion in this Symposium),7 to civil liability for transfusion-associated
AIDS; from the rights and duties of staff health care professionals
who wish to avoid contact with AIDS patients being treated at the in-
stitutions where they work, to the rights and duties of health care pro-
2. The story first broke in The New Journal, a magazine edited by Yale students,
though Ms. Locklear was there referred to pseudonymously as "Lana." Sides,
Lana: A Story of Scarlet Letters and Public Risks, THE NEW JoURNAL, Dec. 9,
1983, at 16. Shortly thereafter, the New Haven papers picked up the story, see
Barbuto, AIDS Risk: Prostitute Suspected as Carrier, New Haven Register, Jan.
23, 1984, at 1, col. 1, and ran a series of stories about her until her death. See, eg.,
Hladky, Carlotta Locklear dies; autopsy due, The New Haven Journal-Courier,
Jan. 15, 1985, at 1, col. 1. CBS aired her story in February, 1984. Id. at 3, col. 2.
3. P.A. 84-336, § 1, 1984 Conn. Acts - (Reg. Sess.) (amending CONN. GEN. STAT. 19a-
221: An Act Concerning Quarantine Measures).
4. Hladky, Carlotta Locklear dies; autopsy due, The New Haven Journal-Courier,
Jan. 15, 1985, at 1, col. 1 & 3, col. 1.
5. Barbuto, Researchers confer on AIDS, drug abusers at health center, The New
Haven Journal-Courier, Dec. 15, 1983 at 1, col. 4.
6. Wallis, AIDS: A Spreading Scourge, TIME, Aug. 5, 1985, at 50.
7. Gray & Melton, The Law and Ethics of Psychosocial Research on AIDS, 64 NEB. L.
REV. 637 (1985).
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fessionals who wish to treat AIDS patients over the objections of
landlords, professional associates, and others. Just as the disease has
spread, so too the literature about these difficult legal problems has
overflowed the professional journals,8 and is beginning to seep into
the popular press.9 And inevitably, as Newsweek has put it, AIDS has
spread to the courts.1 0 The courts have once more become the pri-
mary forum for the resolution of a set of perplexing medicolegal is-
sues, and in that forum public controversy is once more generating
pressures for legal change.
Apparent legal inadequacy in the face of medical change, and the
resulting pressures for legal reform-the field of medical jurispru-
dence has certainly experienced its fair share of this in other instances
already, although it is perhaps unusual for pressures for legal change
to result more from the progress of a disease than the progress of med-
ical science. Legal change in medical jurisprudence is a major theme
of this Symposium, which begins with Sir Zelman Cowen's Roscoe
Pound Lectures, In the Rear and Limping a Little: Some Reflections
on Medicine, Biotechnology and the Law.1 ' Sir Zelman presents a sen-
sitive exploration of complex problems raised when the law, which
must inevitably settle itself with some degree of stability on a ground
of accepted principles, encounters dramatic scientific and technologi-
cal advances in medicine. Joni Gray and Gary Melton's Article, The
Law and Ethics of Psychosocial Research on AIDS,12 draws together
several recent doctrinal developments in bioethics that have changed
the face of the law. They show how these doctrines, protecting in
principle against unnecessarily offensive invasions of privacy and dam-
aging breaches of confidentiality in human-subject research, apply
with special force to the case of psychosocial research on AIDS pa-
tients. In fact, in several respects further protective legal reforms are
needed, and the two authors explore and advocate them. A particular
doctrinal line of legal change is the subject of the article by Diane
Janulis and Alan Hornstein, Damned if You Do, Damned if You
8. See, e.g., Bayer, Levine & Murray, Guidelines for Confidentiality in Research On
AIDS, IRB: A REVIEW OF HuMAN SuBJECTS RESEARCH, Nov.-Dec. 1984, at 1; Cur-
ran, AIDS, Research and "The Window of Opportunity," 312 NEw ENG. J. MED.
903 (1985); Miller, O'Connell, Leipold & Wenzel, Potential Liability for Transfu-
sion-Associated AIDS, 253 J. A.M.A. 3419 (1985); Novick, Quarantine and AIDS,
49 CONN. MED. 81 (1985); Novick, At Risk for AIDS: Confidentiality in Research
Surveillance, IRB, A REviEW OF HumAN SuBJECTs RESEARCH, Nov.-Dec. 1984, at
10.
9. See, e.g., Findlay, USA's 11,871 AIDS Victims Wait, Worry, U.S.A. Today, July
25, 1985, at Al, cols. 3 & 4 & A2 cols. 1 & 2; AIDS Spreads to the Courts, NEWS-
WEEK, July 1, 1985, at 61.
10. AIDS Spreads to the Courts, NEWSWEEK, July 1, 1985, at 61.
11. 64 NEB. L. REV. 548 (1985).
12. 64 NEB. L. REv. 637 (1985).
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Don't: Hospitals'Liability for Physicians' Malpractice,13 a critical sur-
vey of the recent steady expansion of theories of hospital liability for
medical misadventures suffered by patients undergoing hospital
treatment.
Taken together, the remaining pieces in this symposium all focus
explicitly on aspects of physician authority and patient autonomy. But
all importantly involve legal change as well - not only in centering on
the concept of patient autonomy, itself the recent offspring of a course
of legal change in medical jurisprudence - but also in arguing for fur-
ther legal change, or in arguing for correspondingly changed medical
practices in the spirit of the developing law of patient autonomy. Eliz-
abeth Patterson's, The Therapeutic Justification for Withholding
Medical Information: What You Don't Know Can't Hurt You, or Can
It?,14 argues forcefully for a drastic narrowing - perhaps even for the
essential elimination - of the therapeutic privilege, which under spe-
cial circumstances exempts doctors from their ordinary duty to dis-
close the risks and alternatives of treatment. William Winslade and
Judith Wilson Ross explore the related and difficult concepts of pri-
vacy and confidentiality in their Article, Privacy, Confidentiality and
Autonomy in Psychotherapy and Psychoanalysis.15 They argue that
respect for the patient's autonomy requires recognition of the exclu-
sive authority of the patient to determine when confidences shall be
disclosed to persons outside the therapeutic relationship. The con-
cluding casenote, The Scope of the Physician-Patient Privilege in
Criminal Actions: A New Balancing Test,16 argues that related policies
standing behind the attorney-client privilege in the law of evidence
ought to protect the physician in charge of an abortion clinic against
the compulsory disclosure of patients' names to a grand jury investi-
gating unspecified crimes by unspecified persons.
II.
Sir Zelman Cowen's Pound Lectures reflect upon certain insistent
forces for legal reform in medical jurisprudence, arising under the
pressure of striking changes in medicine and biotechnology. These
changes have dramatically enhanced our power over the physiological
processes of birth and death, and appear to have altered the balance of
power between man and nature, bringing fundamental aspects of
these natural processes under conscious human control. Inevitably
these developments are broadly unsettling, altering as they do the giv-
13. 64 NEB. L. REv. 689 (1985).
14. 64 NEB. L. REv. 721 (1985).
15. 64 NEB. L. REV. 578 (1985).
16. 64 NEB. L. REV. 772 (1985).
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ens, the factual setting, of our moral consensus regarding what is and
what is not for man to manipulate.
As Sir Zelman's chosen title implies, his lectures are reflections.
They are indeed deeply and humanely reflective. They show their au-
thor to be sympathetic to the inner imperatives of scientific discovery,
and always willing to consider practical benefits to health, yet at some
point willing to draw the line in the name of what we must preserve of
the human condition as we know it, to safeguard what we believe hu-
manity essentially to be. If the lectures are reflective rather than
closely argued, a complex thesis emerges from them nonetheless: that
the law can and and should adapt itself rapidly if possible, but not
intemperately, to these biotechnical developments. Further, if it is to
do so satisfactorily, it can only do so after lawmakers, first, have con-
sulted the experts and have mastered the relevant biotechnological
data, and, second, have ascertained the general sense of the commu-
nity on the broader moral, social, religious, and economic ideals at
stake. This latter requirement of course presupposes the existence of
an ascertainable consensus, and often makes extraordinary lawmak-
ing processes, such as public consideration by blue-ribbon commis-
sions, especially appropriate.
Lecture One concerns new technologies relating to human tissue
transplantation; Lecture Two, new reproductive technologies. These
are awesome technologies, and they create morally awesome potenti-
alities. There is the human body cerebrally dead, but metabolically
sustained to be farmed for its transplantable parts. There is the
human child who may fairly claim to have five "parents": a sperm do-
nor; an egg donor; a surrogate mother into whose womb the fertile
embryo is implanted so that she may carry it to term; and the mother
and father who raise the child as its legal custodians, and who indeed
may lovingly have sought its conception, thereby initiating the entire
process.
III.
William Winslade and Judith Wilson Ross explore incidents of the
treatment relationship relating to the patient's moral and legal auton-
omy in their Article, Privacy, Confidentiality, and Autonomy in Psy-
chotherapy and Psychoanalysis. The Article focuses upon the special
context of psychotherapeutic treatment. The authors' thesis, how-
ever, applies generally to physician-patient relationships. The authors
initially explore the distinct but related concepts of privacy and confi-
dentiality. They argue that although confidentiality is a relational
concept respecting information shared between persons in a relation-
ship of trust, privacy is a personal concept respecting the exclusive
control that individuals must be accorded over certain self-referring
information. Nevertheless, they maintain that confidentiality is a de-
1985]
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rivative value depending essentially upon privacy. Confidential infor-
mation is private information confided to another, that is, disclosed to
another in a relation of trust on the understanding that it is not fur-
ther to be divulged - not, at any rate, without the confider's consent.
In professional relationships, the client's expectation of controlling
further disclosure shows that the client, by confiding her secret to the
professional, has only agreed to a limited relinquishment of her
autonomy.
The law, the authors continue, seems to recognize the client or pa-
tient, not the professional, as the holder of all rights to the continued
privacy of confidential information. Unfortunately, the various codes
of conduct of the psychotherapeutic professions, and their actual prac-
tices relating to secrecy or disclosure, seem to adopt the paternalistic
attitude that decisions about the protection of patient confidences,
even when made in the patient's apparent therapeutic interest, are for
the therapist to make: it is the therapist who controls the further pri-
vacy of the information. This fails to make sense either of the pa-
tient's autonomy, or of her equal dignity as a person, and it violates the
patient's expectation that she will be in control of the continued pri-
vacy of her medical information beyond the confines of the therapeu-
tic relationship. The authors reinforce their argument, explaining
how their conception of personal privacy as a form of control over in-
formation that must continue, even after confidential information has
once been disclosed in the professional relationship, is therapeutically
beneficial and need not conflict significantly with the therapist's as-
sessment of what course of treatment will most clearly further the
patient's cure.
All rights of privacy and confidentiality belong to patients, not to
therapists. Once this is recognized, the authors conclude, a decent re-
spect for the patient's autonomy and dignity, even perhaps for his
prospects for a cure, demands first, that the patient be given sufficient
notice of any disclosures that the therapist is by law required to make,
and second, that the patient have the exclusive power to permit or to
forbid any other disclosures that the therapist might wish to make,
even in the patient's own interest.
IV.
As Joni Gray and Gary Melton point out toward the opening of
their Article, The Law and Ethics of Psychosocial Research on AIDS,
the varying interests of human subject, researcher, and society fre-
quently come into conflict in medical and behavioral research on
human subjects. In all such research there are at least these poten-
tially divergent interests at stake: the social interest in advancing the
general welfare by deepening and broadening our understanding of
the human condition; the researcher's separate proprietary interest in
[Vol. 64:537
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advancing a career through maximizing her chances that the results
will be favorably received in the research community; and the sub-
ject's personal interests, which are typically some combination of al-
truism, curiosity, a desire for any available monetary or other
compensating reward, and the hope that the research may lead to the
more effective treatment of his own condition.
In the case of psychosocial research on AIDS these conflicts are
almost unbearably acute. First of all, in striking primarily gay men
and intravenous drug abusers, AIDS has victimized members of
groups already socially stigmatized. Second, the apparent transmis-
sion of AIDS through illicit drug use or sexual intimacy requires re-
search into areas ordinarily accorded the highest degree of personal
privacy. Third, the continuing rapid spread and apparently fatal prog-
nosis of AIDS require our utmost efforts to understand and eradicate
it. And fourth, some combination of these factors has caused, or at
least has substantially contributed to, the creation of an overheated
climate of opinion, verging on public hysteria, about the disease. The
magnitude of the medical risk from the AIDS epidemic is great, and
the need for research and knowledge is correspondingly high. Against
this must be weighed the individual needs of AIDS research subjects;
given the stigma attached to mere participation in such research, their
needs for confidentialty and for privacy are also substantial.
Psychosocial research on AIDS is therefore painfully sensitive.
The authors quite effectively demonstrate those reasons for which
psychosocial research on AIDS is more than ordinarily susceptible to
invading the subject's privacy, diminishing his autonomy, or betraying
his confidences. They then explore certain specific problems of in-
formed consent, intrusiveness, and confidentiality arising in the design
and conduct of research studies, the recruiting of subjects for them,
and the reporting of research results. In the interest of minimizing
risk to the research subject, of assuring that his choice to participate is
free and informed, of preserving his right to withdraw, and of protect-
ing his confidential information, Ms. Gray and Mr. Melton make a
number of practical suggestions that must be regarded as more in the
nature of research imperatives, in view of the gravity and sensitivity of
AIDS research. Finally, they demonstrate that the law now quite in-
adequately protects certain vital interests of AIDS research subjects.
In response, they advocate necessary legal reforms, and suggest how
researchers in the meantime might go about protecting their subjects'
interests as fully as possible under the current law. Their Article
closes with an Appendix, "Proposed Guidelines for Informed Consent
to Psychosocial Research on AIDS," an extremely thoughtful treat-
ment of elements and procedures in obtaining the informed and free
consent of subjects in an AIDS study. Anyone generally interested in
bioethical developments in medical jurisprudence, and in the larger
1985]
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theme of legal change in response to morally controversial develop-
ments in medicine and health, or in the legal and ethical implications
of research on human subjects, should read this Article.
V.
In Damned if You Do, Damned if You Don't: Hospitals' Liability
for Physicians' Malpractice, Diane Janulis and Alan Hornstein ex-
amine the current doctrines of hospital liability to patients harmed by
medical misadventure caused by a physician during hospital care.
Each major theory of relief - respondeat superior, ostensible or ap-
parent agency, estoppel to deny agency, and corporate negligence - is
reviewed. Against this background of developing legal theories of hos-
pital liability for harms caused by independent physicians with staff
privileges, Ms. Janulis and Mr. Hornstein explore not only some of the
pressures favoring continued expansion of hospital tort liability for
physician malpractice, but also some of the countervailing obstacles to
effective hospital monitoring of the quality of care provided by staff
physicians.
The authors' primary thesis is that, because of the inconsistent,
sometimes conflicting, and constantly changing, social pressures to
which hospitals are subject, it is still unclear whether hospitals will be
able to meet their expanding obligations in ways that are to the ulti-
mate social good. Before this will ever become clear, we must clarify
the hospital's role in the provision of care; only then can we determine
the hospital's soundest mandate in the assurance of the quality of
medical care. Ms. Janulis and Mr. Hornstein argue their point vigor-
ously. Even the reader who disagrees will find a fuller airing of the
issues than most courts have yet given them, as well as a good sum-
mary of observable trends in this branch of the law.
VI.
The law places the physician under important duties, one of which
is disclosing to the patient the risks of treatment, so as to assure that
the patient's consent to treatment be fully informed. Many courts
have carved out an exception to those duties, allowing nondisclosure
of risk when the mere knowledge or discussion of the risk would rep-
resent an independent threat to the patient's health, or as the doctors
might put it, when risk disclosure is medically contraindicated. In
such a case, concealment of risks furthers a therapeutic purpose, and
so this exception to the usual duty of disclosure has come to be called
the therapeutic privilege. Elizabeth Patterson mounts a sustained at-
tack on the privilege in her Article, The Therapeutic Justification for
Withholding Medical Information: What You Don't Know Can't Hurt
You, or Can It?
[Vol. 64:537
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Ms. Patterson is surely correct to argue that the therapeutic privi-
lege has been, at best, only imperfectly understood; in fact it appears
more frequently in dictum than in decision. In principle only a nar-
row version of the privilege is defensible, allowing physicians to with-
hold risk information only when the information carries a serious risk
of causing anxiety-related health problems: "Because of the impor-
tance of autonomy, the justification for nondisclosure must require at
a minimum a significant likelihood of a substantial negative effect."17
So conceived, the principle finds only relatively feeble support from
the current state of the medical arts. We do know that certain stres-
sors can cause anxiety-related health disorders, some of them quite
grave, but this is virtually all that we know. We are as yet medically
quite unsophisticated in predicting what type of disclosure of what
type of risk will, by acting as a psychological stressor, cause a disease
or anxiety disorder in what type of person. And since studies suggest
that a major source of the patient's anxiety is what the patient does
not know, nondisclosure of risk may be a major stressor itself, doing
harm more often than avoiding it.
As Ms. Patterson further argues, the therapeutic privilege cen-
trally undercuts the very purpose of informed consent rules, which
serve to assure that treatment decisions are for patients to make
freely and autonomously, provided, of course, that they are competent
to do so. Patients must be free to reject any proferred course of ther-
apy, however promising its expected benefits, and regardless what
therapy health care providers would order were they empowered to
issue binding treatment directives to their patients. All relevant medi-
cal information, especially information respecting risks of a particular
treatment and alternatives to it, can bear on the patient's choice
whether to undergo treatment. The physician who exercises an au-
thority to withhold this information thereby deprives the patient of
some part of the patients's own decision-making authority. Hence a
decision not to disclose risks of treatment exerts an undefined but im-
portant governing influence over the patient's choice of treatment.
When nondisclosure is premised on the patient's own health, as it is
when it is therapeutically privileged, the nondisclosure decision is it-
self a treatment decision: a decision that a particular course of action
- namely, nondisclosure - is in the patient's best medical interests.
The nondisclosure decision, however, is thrust upon the patient,
whose autonomy is thereby proportionately diminished, for the pa-
tient is of course not asked to consent to nondisclosure. Why not? If
there is a principled distinction between the therapy of nondisclosure
in cases in which risk information may create separate stress-related
threats to the patient's health, and other therapies that patients are
17. Patterson, supra note 14, at 738.
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required to choose freely, it is perhaps that presenting the patient with
the choice whether to receive anxiety-producing risk information is
enough to do the harm that nondisclosure would avert. Such a choice
might be presented in terms like these:
As your physician, ordinarily I would describe the risks of your treatment.
But sometimes just knowing the risks causes intense worrying, and the worry-
ing in turn may further damage your health. The choice is yours; but, know-
ing how worrisome the risks of your treatment might be, I thought that
perhaps you'd rather forego that part of our discussion.
The existence of undisclosed risks, serious enough that informa-
tion about them alone may cause stress-related harms to health, may
well make the stress-prone patient brood over the danger, thereby
harming his health. If this is so, there can be no effective choice by
patients. Either the physician alone decides that risk disclosure is
likely to be harmful, and makes no disclosure of any kind, thereby
protecting only the interest of all patients who might have chosen
therapeutic nondisclosure, and imposing nondisclosure upon the
others. Or the physician presents the patient with the choice, thereby
telegraphing something about risk, protecting only the interest of pa-
tients who might have chosen risk disclosure and imposing risk infor-
mation upon the others. Ms. Patterson concludes her Article with a
proposal for a form of advance consent, requested early in the treat-
ment relationship, that would protect the autonomy of all patients,
even those who would elect nondisclosure for therapeutic reasons,
without unduly risking that the choice itself will be harmful to the
patient's health.
VII.
The Symposium closes with a casenote. In People v. Florendo,S
the Illinois Supreme Court held that the names of patients visiting an
abortion clinic were not privileged against disclosure in response to a
grand jury subpoena served upon the physician in charge of the clinic.
The court reasoned that the public interest in unfettered grand jury
investigations outweighs any interest that the individual patients
might have in the secrecy of their names. The author argues that the
case was wrongly decided, since protecting this information furthers
the basic interest behind the physician-patient privilege, the interest
in encouraging confidential disclosures by the patient in aid of treat-
ment. Shielding the names of these patients from discovery in this
case would therefore square with legislative policy. Furthermore,
statutory and constitutional rights of privacy should protect the se-
crecy of the patients' names in this case, absent any compelling state
interest in disclosure. No such state interest is apparent; the bare
18. 95 Ill. 2d 155, 447 N.E. 2d 282 (1983).
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claim to an interest in unfettered grand jury investigations, unsup-
ported by any showing of need for this information, cannot suffice.
VIII. CONCLUSION
Thus the casenote concludes the Symposium with a plea for rejec-
tion of the rule in People v. Florendo, a limited call for legal change,
leaving us with yet another reflection on the topic with which the
Symposium began, legal flux in medical jurisprudence. How, when,
and in what particulars should the laws change to accomodate medical
advances when fundamental values are implicated? These remain
vexing questions. Is the reader now any the wiser? Read the Sympo-
sium, and reflect.
